 | • レポートコード：MRC2-11QY11377 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はリキッドバイオプシー用循環バイオマーカーのグローバル市場について調査・分析したレポートです。種類別（循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、無細胞DNA（cfDNA）、細胞外小胞（EV）、その他）市場規模、用途別（早期がん検診、治療法選択、治療モニタリング、再発モニタリング整形外科）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別リキッドバイオプシー用循環バイオマーカーの競争状況、市場シェア ・世界のリキッドバイオプシー用循環バイオマーカー市場：種類別市場規模 2015年-2020年（循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、無細胞DNA（cfDNA）、細胞外小胞（EV）、その他） ・世界のリキッドバイオプシー用循環バイオマーカー市場：種類別市場規模予測 2021年-2026年（循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、無細胞DNA（cfDNA）、細胞外小胞（EV）、その他） ・世界のリキッドバイオプシー用循環バイオマーカー市場：用途別市場規模 2015年-2020年（早期がん検診、治療法選択、治療モニタリング、再発モニタリング整形外科） ・世界のリキッドバイオプシー用循環バイオマーカー市場：用途別市場規模予測 2021年-2026年（早期がん検診、治療法選択、治療モニタリング、再発モニタリング整形外科） ・北米のリキッドバイオプシー用循環バイオマーカー市場分析：米国、カナダ ・ヨーロッパのリキッドバイオプシー用循環バイオマーカー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのリキッドバイオプシー用循環バイオマーカー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のリキッドバイオプシー用循環バイオマーカー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのリキッドバイオプシー用循環バイオマーカー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Becton, Dickinson and Company、GE Healthcare、Epigenomics AG、Agilent Technologies、Biocept、Affymetrix、Fluxion Biosciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Circulating Biomarker for Liquid Biopsy Market
The global Circulating Biomarker for Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Circulating Biomarker for Liquid Biopsy Scope and Market Size
Circulating Biomarker for Liquid Biopsy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Circulating Biomarker for Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
Market segment by Type, the product can be split into
Circulating Tumor Cells (CTCs)
Circulating Tumor DNA (ctDNA)
Cell-Free DNA (cfDNA)
Extracellular Vesicles (EVs)
Others
Market segment by Application, split into
Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring Orthopedics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Circulating Biomarker for Liquid Biopsy Revenue
1.4 Market by Type
1.4.1 Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Circulating Tumor Cells (CTCs)
1.4.3 Circulating Tumor DNA (ctDNA)
1.4.4 Cell-Free DNA (cfDNA)
1.4.5 Extracellular Vesicles (EVs)
1.4.6 Others
1.5 Market by Application
1.5.1 Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2020 VS 2026
1.5.2 Early Cancer Screening
1.5.3 Therapy Selection
1.5.4 Treatment Monitoring
1.5.5 Recurrence Monitoring Orthopedics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Circulating Biomarker for Liquid Biopsy Market Perspective (2015-2026)
2.2 Global Circulating Biomarker for Liquid Biopsy Growth Trends by Regions
2.2.1 Circulating Biomarker for Liquid Biopsy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Circulating Biomarker for Liquid Biopsy Historic Market Share by Regions (2015-2020)
2.2.3 Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Circulating Biomarker for Liquid Biopsy Market Growth Strategy
2.3.6 Primary Interviews with Key Circulating Biomarker for Liquid Biopsy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Market Size
3.1.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue (2015-2020)
3.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Players (2015-2020)
3.1.3 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio
3.2.1 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Circulating Biomarker for Liquid Biopsy Revenue in 2019
3.3 Circulating Biomarker for Liquid Biopsy Key Players Head office and Area Served
3.4 Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
3.5 Date of Enter into Circulating Biomarker for Liquid Biopsy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Type (2015-2020)
4.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
5.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
6.2 Circulating Biomarker for Liquid Biopsy Key Players in North America (2019-2020)
6.3 North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
6.4 North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
7.2 Circulating Biomarker for Liquid Biopsy Key Players in Europe (2019-2020)
7.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
7.4 Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
8 China
8.1 China Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
8.2 Circulating Biomarker for Liquid Biopsy Key Players in China (2019-2020)
8.3 China Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
8.4 China Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
9.2 Circulating Biomarker for Liquid Biopsy Key Players in Japan (2019-2020)
9.3 Japan Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
9.4 Japan Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
10.2 Circulating Biomarker for Liquid Biopsy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
10.4 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
11 India
11.1 India Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
11.2 Circulating Biomarker for Liquid Biopsy Key Players in India (2019-2020)
11.3 India Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
11.4 India Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Circulating Biomarker for Liquid Biopsy Market Size (2015-2020)
12.2 Circulating Biomarker for Liquid Biopsy Key Players in Central & South America (2019-2020)
12.3 Central & South America Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020)
12.4 Central & South America Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Introduction
13.1.4 Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Becton, Dickinson and Company
13.2.1 Becton, Dickinson and Company Company Details
13.2.2 Becton, Dickinson and Company Business Overview
13.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Introduction
13.2.4 Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
13.2.5 Becton, Dickinson and Company Recent Development
13.3 GE Healthcare
13.3.1 GE Healthcare Company Details
13.3.2 GE Healthcare Business Overview
13.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Introduction
13.3.4 GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
13.3.5 GE Healthcare Recent Development
13.4 Epigenomics AG
13.4.1 Epigenomics AG Company Details
13.4.2 Epigenomics AG Business Overview
13.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Introduction
13.4.4 Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
13.4.5 Epigenomics AG Recent Development
13.5 Agilent Technologies
13.5.1 Agilent Technologies Company Details
13.5.2 Agilent Technologies Business Overview
13.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Introduction
13.5.4 Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
13.5.5 Agilent Technologies Recent Development
13.6 Biocept
13.6.1 Biocept Company Details
13.6.2 Biocept Business Overview
13.6.3 Biocept Circulating Biomarker for Liquid Biopsy Introduction
13.6.4 Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
13.6.5 Biocept Recent Development
13.7 Affymetrix
13.7.1 Affymetrix Company Details
13.7.2 Affymetrix Business Overview
13.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Introduction
13.7.4 Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
13.7.5 Affymetrix Recent Development
13.8 Fluxion Biosciences
13.8.1 Fluxion Biosciences Company Details
13.8.2 Fluxion Biosciences Business Overview
13.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Introduction
13.8.4 Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020)
13.8.5 Fluxion Biosciences Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Circulating Biomarker for Liquid Biopsy Key Market Segments
Table 2. Key Players Covered: Ranking by Circulating Biomarker for Liquid Biopsy Revenue
Table 3. Ranking of Global Top Circulating Biomarker for Liquid Biopsy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Circulating Tumor Cells (CTCs)
Table 6. Key Players of Circulating Tumor DNA (ctDNA)
Table 7. Key Players of Cell-Free DNA (cfDNA)
Table 8. Key Players of Extracellular Vesicles (EVs)
Table 9. Key Players of Others
Table 10. Global Circulating Biomarker for Liquid Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Circulating Biomarker for Liquid Biopsy Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Circulating Biomarker for Liquid Biopsy Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions (2015-2020)
Table 14. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Circulating Biomarker for Liquid Biopsy Market Growth Strategy
Table 20. Main Points Interviewed from Key Circulating Biomarker for Liquid Biopsy Players
Table 21. Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2015-2020) (Million US$)
Table 22. Global Circulating Biomarker for Liquid Biopsy Market Share by Players (2015-2020)
Table 23. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2019)
Table 24. Global Circulating Biomarker for Liquid Biopsy by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
Table 27. Date of Enter into Circulating Biomarker for Liquid Biopsy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 30. Global Circulating Biomarker for Liquid Biopsy Market Size Share by Type (2015-2020)
Table 31. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2021-2026)
Table 32. Global Circulating Biomarker for Liquid Biopsy Market Size Share by Application (2015-2020)
Table 33. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 34. Global Circulating Biomarker for Liquid Biopsy Market Size Share by Application (2021-2026)
Table 35. North America Key Players Circulating Biomarker for Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Circulating Biomarker for Liquid Biopsy Market Share (2019-2020)
Table 37. North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 38. North America Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 39. North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 40. North America Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 41. Europe Key Players Circulating Biomarker for Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Circulating Biomarker for Liquid Biopsy Market Share (2019-2020)
Table 43. Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 45. Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 47. China Key Players Circulating Biomarker for Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 48. China Key Players Circulating Biomarker for Liquid Biopsy Market Share (2019-2020)
Table 49. China Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 50. China Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 51. China Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 52. China Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 53. Japan Key Players Circulating Biomarker for Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Circulating Biomarker for Liquid Biopsy Market Share (2019-2020)
Table 55. Japan Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 57. Japan Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Circulating Biomarker for Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Circulating Biomarker for Liquid Biopsy Market Share (2019-2020)
Table 61. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 63. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 65. India Key Players Circulating Biomarker for Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 66. India Key Players Circulating Biomarker for Liquid Biopsy Market Share (2019-2020)
Table 67. India Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 68. India Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 69. India Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 70. India Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Circulating Biomarker for Liquid Biopsy Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Circulating Biomarker for Liquid Biopsy Market Share (2019-2020)
Table 73. Central & South America Circulating Biomarker for Liquid Biopsy Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Circulating Biomarker for Liquid Biopsy Market Share by Type (2015-2020)
Table 75. Central & South America Circulating Biomarker for Liquid Biopsy Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Circulating Biomarker for Liquid Biopsy Market Share by Application (2015-2020)
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Product
Table 80. Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (Million US$)
Table 81. Abbott Laboratories Recent Development
Table 82. Becton, Dickinson and Company Company Details
Table 83. Becton, Dickinson and Company Business Overview
Table 84. Becton, Dickinson and Company Product
Table 85. Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (Million US$)
Table 86. Becton, Dickinson and Company Recent Development
Table 87. GE Healthcare Company Details
Table 88. GE Healthcare Business Overview
Table 89. GE Healthcare Product
Table 90. GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (Million US$)
Table 91. GE Healthcare Recent Development
Table 92. Epigenomics AG Company Details
Table 93. Epigenomics AG Business Overview
Table 94. Epigenomics AG Product
Table 95. Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (Million US$)
Table 96. Epigenomics AG Recent Development
Table 97. Agilent Technologies Company Details
Table 98. Agilent Technologies Business Overview
Table 99. Agilent Technologies Product
Table 100. Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (Million US$)
Table 101. Agilent Technologies Recent Development
Table 102. Biocept Company Details
Table 103. Biocept Business Overview
Table 104. Biocept Product
Table 105. Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (Million US$)
Table 106. Biocept Recent Development
Table 107. Affymetrix Company Details
Table 108. Affymetrix Business Overview
Table 109. Affymetrix Product
Table 110. Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (Million US$)
Table 111. Affymetrix Recent Development
Table 112. Fluxion Biosciences Business Overview
Table 113. Fluxion Biosciences Product
Table 114. Fluxion Biosciences Company Details
Table 115. Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2015-2020) (Million US$)
Table 116. Fluxion Biosciences Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Biomarker for Liquid Biopsy Market Share by Type: 2020 VS 2026
Figure 2. Circulating Tumor Cells (CTCs) Features
Figure 3. Circulating Tumor DNA (ctDNA) Features
Figure 4. Cell-Free DNA (cfDNA) Features
Figure 5. Extracellular Vesicles (EVs) Features
Figure 6. Others Features
Figure 7. Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2020 VS 2026
Figure 8. Early Cancer Screening Case Studies
Figure 9. Therapy Selection Case Studies
Figure 10. Treatment Monitoring Case Studies
Figure 11. Recurrence Monitoring Orthopedics Case Studies
Figure 12. Circulating Biomarker for Liquid Biopsy Report Years Considered
Figure 13. Global Circulating Biomarker for Liquid Biopsy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions: 2020 VS 2026
Figure 15. Global Circulating Biomarker for Liquid Biopsy Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Circulating Biomarker for Liquid Biopsy Market Share by Players in 2019
Figure 18. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue in 2019
Figure 20. North America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
循環腫瘍細胞（CTC）予後技術の世界市場（～2026年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…- 循環バイオマーカーの世界市場（～2026年） Market Analysis and Insights: Global Circulating Biomarker Market The global Circulating Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Circulating Biomarker Scope and Market Size Circulating Biomarker marke…
- 循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 乳癌リキッドバイオプシーの世界市場（～2026年） Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers. Market Analysis and Insights: Global Breast Cancer …
- 循環腫瘍細胞（CTC）の世界市場（～2026年） Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potenti…